Scrip
First drug approval for Genmab with Arzerra for leukaemia in the US
27 October 2009
Malini Guha
Genmab has secured its first approval of one of its drugs after the US
FDA granted its anti-CD20 monoclonal antibody drug Arzerra (ofatumumab) accelerated approval for a group of heavily pre-treated, refractory patients with chronic lymphocytic leukaemia (CLL).
"The approval of Arzerra brings...
Please Login to read the full article.
27 October 2009
Malini Guha
"The approval of Arzerra brings...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
